Functional hemispherectomy in adults with intractable epilepsy syndromes: a report of 4 cases.
BACKGROUND
Functional hemispherectomy (FH) is mainly performed in children with catastrophic epilepsies and pre-existing severe hemiparesis. It is accepted that mainly patients at young ages with more or less complete loss of their hand function are suitable candidates for FH. However, we feel that FH should be considered also in some adults with devastating unilateral epilepsy syndromes.


METHODS
We report four cases of adults who underwent FH because of their intractable epilepsy syndromes. Three of the four patients had reduced but not complete loss of hand function. Careful weighing-up of the risk-benefit ratio still led to the decision to perform FH in order to achieve complete seizure relief.


RESULTS
All patients had a surgical outcome of Engel class I; one of them suffered from post-operative psychogenic non-epileptic seizures which were treated successfully by psychotherapy. No clinically relevant complications occurred.


CONCLUSIONS
We wish to point out that FH is a possible surgical option in cases with catastrophic epilepsies in adulthood. Patients and relatives should strongly consider that the likelihood of at least partially, impaired hand function or other surgery-related additional handicaps may be outweighed by the chance of freedom of seizures in a limited number of patients. In all of our cases, patients and relatives agreed that the surgical outcome led to a marked improvement of quality of life and that it had been the right decision to proceed with FH in spite of the expected negative impacts of the operation. Video examples of the pre- and post-surgical hand function of one sample patient are enclosed.
Kork Epilepsy Center, Kehl-Kork, Germany. bsteinhoff@epilepsiezentrum.de
Bernhard J
BJ
Steinhoff
Anke Maren
AM
Staack
Sofia
S
Bilic
Uwe
U
Kraus
Andreas
A
Schulze-Bonhage
Josef
J
Zentner
D000203:Activities of Daily Living; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications / Q000473:pathology / Q000601:surgery; D004351:Drug Resistance; D004827:Epilepsy / Q000188:drug therapy / Q000523:psychology / Q000601:surgery*; D056344:Executive Function / Q000502:physiology; D005260:Female; D006408:Hematoma, Subdural / Q000601:surgery; D038421:Hemispherectomy / Q000009:adverse effects; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D018191:Lymphangioma, Cystic / Q000150:complications / Q000473:pathology / Q000601:surgery; D008279:Magnetic Resonance Imaging; D008297:Male; D008606:Mental Processes / Q000502:physiology; D009044:Motor Cortex / Q000601:surgery; D010291:Paresis / Q000209:etiology / Q000601:surgery; D011183:Postoperative Complications / Q000473:pathology; D018570:Risk Assessment; D013226:Status Epilepticus; D016896:Treatment Outcome; D055815:Young Adult
D000927:Anticonvulsants